| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.39M | 99.36M | 75.80M | 141.12M | 137.39M | 95.36M |
| Gross Profit | 10.82M | 23.84M | 13.32M | 52.12M | 47.41M | 30.27M |
| EBITDA | -13.53M | -338.00K | -8.78M | 30.12M | 25.10M | 11.63M |
| Net Income | -22.80M | -11.62M | -17.88M | 15.81M | 14.57M | 3.24M |
Balance Sheet | ||||||
| Total Assets | 334.03M | 339.31M | 358.70M | 370.07M | 332.44M | 298.86M |
| Cash, Cash Equivalents and Short-Term Investments | 23.11M | 22.83M | 39.89M | 44.29M | 42.18M | 72.84M |
| Total Debt | 63.70M | 49.78M | 55.73M | 48.88M | 16.54M | 13.23M |
| Total Liabilities | 93.58M | 84.41M | 89.56M | 80.33M | 52.21M | 43.33M |
| Stockholders Equity | 179.15M | 192.77M | 203.99M | 221.61M | 211.53M | 192.62M |
Cash Flow | ||||||
| Free Cash Flow | -18.93M | -17.88M | -7.07M | -37.23M | -32.95M | -13.99M |
| Operating Cash Flow | -15.80M | -12.11M | 3.40M | -8.77M | -3.31M | 5.87M |
| Investing Cash Flow | -4.24M | -4.45M | -2.60M | -25.22M | -38.81M | -16.42M |
| Financing Cash Flow | 6.71M | -536.00K | 8.61M | 38.03M | 5.72M | 52.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $314.63M | 22.76 | 22.20% | 6.28% | -9.48% | -14.28% | |
65 Neutral | $260.56M | -456.00 | -0.91% | ― | -0.41% | -134.49% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $213.94M | -7.23 | -23.56% | ― | 7.53% | -15.00% | |
50 Neutral | $1.22B | -41.92 | -12.00% | ― | -4.54% | -119.39% | |
49 Neutral | $282.65M | 40.48 | 1.74% | ― | -10.74% | ― | |
46 Neutral | $75.08M | -3.51 | -116.86% | ― | -94.26% | 3.20% |
On January 8, 2026, AXT updated its revenue expectations for the fourth quarter of 2025, projecting sales of $22.5 million to $23.5 million, a reduction primarily attributed to fewer-than-anticipated export control permits for indium phosphide issued by China’s Ministry of Commerce, which constrained shipments in December despite strong customer demand. Management highlighted that the company remains in the early stages of a multi-year growth cycle driven by AI-related infrastructure and high-speed optical connectivity, is on track to more than double indium phosphide capacity in the second half of 2026, and intends to deploy proceeds from a December capital raise to expand manufacturing capacity for anticipated data center growth; AXT also scheduled its fourth-quarter 2025 earnings release and call for February 19, 2026 and confirmed its participation in the 28th Annual Needham Growth Conference in New York on January 14, 2026.
The most recent analyst rating on (AXTI) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.
On December 29, 2025, AXT, Inc. entered into an underwriting agreement for a public offering of 7,098,492 shares of common stock at $12.25 per share, targeting gross proceeds of about $87 million, with a 30-day option granted to underwriters for an additional 1,064,773 shares that could lift total gross proceeds to roughly $100 million; the deal, led by Northland Securities with Wedbush Securities and Craig-Hallum as co-managers, was expected to close on or about December 30, 2025, and included customary representations, closing conditions and a 60-day lock-up commitment from AXT’s executives and directors. On the same day, the underwriters fully exercised the over-allotment option, securing an additional $13.0 million in anticipated gross proceeds and positioning AXT to direct the net funds toward expanding indium phosphide substrate manufacturing capacity at its Beijing Tongmei subsidiary for global export, supporting research and development, and strengthening working capital and general corporate resources, potentially enhancing its ability to meet growing demand in advanced compound semiconductor markets.
The most recent analyst rating on (AXTI) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.